In OSCC, overexpression of miR-626 targets and inhibits RASSF4 translation, whereas in acute myeloid leukemia (AML), GATA-binding protein 2 (GATA2) significantly reduces RASSF4 expression levels [29,45]. Here, GATA2 is linked to acute myeloid leukemia.